Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
Neuropsychologist Victoria M. Leavitt, PhD is featured in three EveryDay Health podcasts about recognizing and treating patients with mild cognitive impairment.
A new collaborative study by Drs. Martin Picard and Philip L. De Jager examines the potential link between the brain's mitochondria and a person's psychological stress.
Yaakov Stern, PhD, Florence Irving Professor of Neuropsychology in the Department of Neurology at Columbia University Irving Medical Center talks about his research on cognition and aging.
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
Various programs around the country connect neurologic patients and caregivers with the arts. One such example is Arts & Minds, an organization founded by Dr. James M. Noble
Vagelos College of Physicians and Surgeons and College of Dental Medicine scientists awarded $3.97 million to study link between Alzheimer’s and periodontitis
Dr. Manly was elected to NAM for her pioneering work improving detection of cognitive impairment among racially, culturally, and socio-economically diverse adults